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Abstract
Background: Antibiotics which inhibit bacterial peptidoglycan biosynthesis are the most widely used in current
clinical practice. Nevertheless, resistant strains increase dramatically, with serious economic impact and effects on
public health, and are responsible for thousands of deaths each year. Critical clinical situations should benefit from
a rapid procedure to evaluate the sensitivity or resistance to antibiotics that act at the cell wall. We have adapted a
kit for rapid determination of bacterial DNA fragmentation, to assess cell wall integrity.
Results: Cells incubated with the antibiotic were embedded in an agarose microgel on a slide, incubated in an
adapted lysis buffer, stained with a DNA fluorochrome, SYBR Gold and observed under fluorescence microscopy. The
lysis affects the cells differentially, depending on the integrity of the wall. If the bacterium is susceptible to the
antibiotic, the weakened cell wall is affected by the lysing solution so the nucleoid of DNA contained inside the
bacterium is released and spread. Alternatively, if the bacterium is resistant to the antibiotic, it is practically unaffected
by the lysis solution and does not liberate the nucleoid, retaining its normal morphological appearance. In an initial
approach, the procedure accurately discriminates susceptible, intermediate and resistant strains of Escherichia coli to
amoxicillin/clavulanic acid. When the bacteria came from an exponentially growing liquid culture, the effect on the cell
wall of the b-lactam was evident much earlier that when they came from an agar plate. A dose-response experiment
with an E. coli strain susceptible to ampicillin demonstrated a weak effect before the MIC dose. The cell wall damage
was not homogenous among the different cells, but the level of damage increased as dose increased with a
predominant degree of effect for each dose. A microgranular-fibrilar extracellular background was evident in gram-
negative susceptible strains after b-lactam treatment. This material was digested by DNase I, hybridised with a specific
whole genome probe, and so recognized as DNA fragments released by the bacteria. Finally, 46 clinical strains from
eight gram-negative and four gram-positive species were evaluated blind for susceptibility or resistance to one of four
different b-lactams and vancomycin, confirming the applicability of the methodology.
Conclusion: The technique to assess cell wall integrity appears to be a rapid and simple procedure to identify
resistant and susceptible strains to antibiotics that interfere with peptidoglycan biosynthesis.
Background
The bacterial cell wall provides shape, with resistance to
mechanical stress and to internal osmotic forces. Peptido-
glycan or murein is an important component of bacterial
cell wall. This forms an enormous network of interlinked
chains of alternating subunits of N-acetylglucosamine
(NAG) and N-acetylmuramic acid (NAM). Short stem
peptides that are attached to NAM are cross-linked to
stem peptides from nearby muropeptide strands. Peptido-
glycan components are synthesized and assembled in the
cytoplasm and transferred to the outer face of the cyto-
plasmic membrane. There, the penicillin-binding proteins
(PBPs) or DD-peptidases catalyze the formation of glycosi-
dic linkages between two muropeptide units producing
linear glycan chains and the formation of the peptide
bonds between adjacent murein strands, i.e.
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transpeptidation, resulting in a rigid tridimensional poly-
mer [1-3]. Whereas gram-negative bacteria contain two to
five layers of peptidoglycan, gram-positive bacteria exhibit
a much thicker cell wall, with teichoic acids attached to
the peptidoglycan and to the cytoplasmic membrane.
Moreover, there is variability among different species and
strains, in the frequency of crosslinking in the peptidogly-
can and in the presence of different molecules incorpo-
rated into the peptidoglycan [3].
Antibiotics that inhibit bacterial cell wall biosynthesis
are the most widely used in current clinical practice [1].
The largest family corresponds to b-lactams, which
include penicillins, cephalosporins, carbapenems, mono-
bactams and b-lactamase inhibitors [4]. These antibiotics
are analogues of D-alanyl-D-alanine, the terminal aminoa-
cid residues on the precursor NAG/NAM-peptide subu-
nits, thus interacting with the active center of PBPs and
covalently reacting with a serine residue. They mainly
inhibit the transpeptidation, thus stopping cell growth.
Secondarily, a build-up of peptidoglycan precursors trig-
gers murein hydrolases or autolysins, degrading the pepti-
doglycan and resulting in cell death [5]. In the case of
gram-positive bacteria, the teichoic acids that inhibit the
autolytic system are lost, so the associated murein hydro-
lases are activated and degrade the peptidoglycan [3].
Resistance to b-lactams may be due to alterations in
the permeability of cell wall, loss or mutation of porins,
increased expression of active efflux pumps, and over-
synthesis or alteration of PBPs. Nevertheless, the most
frequent mechanism is the production of b-lactamases,
that hydrolize the b-lactam ring [6,7]. Whereas some b-
lactamases degrade specific b-lactams, a great concern
exists with respect to extended-spectrum b-lactamases
(ESBL) [8].
Besides b-lactams, other antibiotics affect peptidogly-
can, acting on different stages of biosynthesis. One of
the most relevant is vancomycin, a glycopeptide that
binds to terminal D-alanyl-D-alanine from the penta-
peptide of the cell wall in gram-positive bacteria, block-
ing the incorporation of peptides to the cell wall, thus
inhibiting peptydoglicane elongation [9]. Vancomycin is
the last-line antibiotic for severe gram-positive infec-
tions, so the growing increase in resistance is a serious
health problem [10]. One mechanism of resistance to
vancomycin appears to be alteration to the terminal
aminoacid residues of the NAM/NAG-peptide subunits,
normally D-alanyl-D-alanine, which vancomycin binds
to, decreasing drug affinity [11].
The increase in the number of resistant and multire-
sistant strains of bacteria is a major concern for health
officials worldwide, with severe impact on economy and
in public health [12]. Resistance is responsible of thou-
sands of deaths each year. Many of them could be pre-
vented by a rapid detection of the resistant bacteria and
prompt administration of the appropriate antibiotic.
This is particularly decisive in life-threatening infections
or for patients in the intensive care unit [13]. In this
case, empirical treatment fails in 20-40% cases, and the
change of antibiotic based on late classic antibiogram
results may be not successful. Critical clinical situations
should benefit from a rapid procedure to evaluate the
sensitivity or resistance to antibiotics. Moreover, a cor-
rect initial treatment, besides avoiding treatment failure,
can prevent the spreading of resistant microorganisms
through misuse of antibiotics.
We have recently validated a rapid and simple techni-
que to determine in situ, and at the single-cell level, the
susceptibility or resistance to quinolones, which induce
DNA double-strand breaks [14-16]. The bacteria are
immersed in an inert microgel on a microscope slide
and incubated in a specific lysis solution that removes
the cell wall, membranes and proteins. In quinolone
sensitive strains, the DNA is fragmented, showing haloes
of peripheral diffusion of DNA fragments emerging
from the residual central core, that are visualized under
fluorescence microscopy after staining with a sensitive
fluorochrome. In case of resistant strains, the nucleoids
liberated appear intact, with limited spreading of DNA
fibre loops. Our purpose was to adapt this simple tech-
nology for a rapid evaluation of the susceptibility or
resistance to antibiotics that affect the cell wall.
To evaluate if bacteria are susceptible or resistant to
quinolones, it is necessary to find lysing conditions that
remove the cell wall from all the cells in the population.
If there were cells not lysed or insufficiently lysed, the
condition of the DNA that remains inside is unknown.
Nevertheless, to assess the efficacy of antibiotics against
the cell wall, the lysis must be adapted to only affect
those bacteria whose cell wall has been damaged by the
antibiotic. The liberation of the nucleoid must be the
marker that indicates that the wall has been lysed, i.e.,
that has been affected by the antibiotic. In case of a
resistant strain, bacteria would be practically unaffected
by the lysis solution and so do not liberate the nucleoid,
which retains its usual morphological appearance under
the microscope.
Results
Identification of susceptibility-resistance in E. coli strains
The technique to evaluate cell wall integrity was initially
assayed in E. coli strains from the clinical microbiology
laboratory. Ten strains were processed blind after incu-
bation with amoxicillin/clavulanic acid at doses 0, 8/4
and 32/16 μg/ml, the CLSI breakpoints of susceptibility
and resistance, respectively. Example images are pre-
sented in Figure 1. Control cultures without antibiotic
(Figure 1 a, b, c) showed the bacteria practically unaf-
fected by the lysis. After 8/4 μg/ml, only bacteria from
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susceptible strains appeared lysed, releasing the
nucleoids (Figure 1a’). After 32/16 μg/ml, susceptible
and intermediate bacteria appeared to be lysed (Figure
1a’’ and 1b’’), whereas the resistant strains did not
spread their nucleoids (Figure 1c’’). Nevertheless, resis-
tance was not homogeneous and some occasional bac-
teria with damaged cell wall could be visible.
Interestingly, a background of extracellular microgranu-
lar-fibrilar material released by the bacteria was
observed with a density dependent on the efficacy of the
antibiotic, thus being especially intense in susceptible
strains exposed to relative high doses. The coincidence
of the results from the technique and the standard clini-
cal laboratory was absolute, so the two susceptible, the
five intermediate and the three resistant strains were
correctly identified.
Nature of the microgranular-fibrilar extracellular
background
To investigate the nature of the background, in situ
digestion with proteinase K and DNase I was performed
without a lysis step on microgels prepared from a strain
of E. coli susceptible to ampicillin and another strain of
A. baumannii susceptible to imipenem. The
Figure 1 Images of susceptible (above: a, a’, a’’), intermediate (medium: b, b’, b’’) and resistant (below: c, c’, c’’) strains from E. coli
incubated with 8/4 μg/ml and 32/16 μg/ml amoxicillin/clavulanic acid and processed by the technique to determine cell wall
integrity. The strain is considered susceptible when its MIC is ≤ 8/4 and resistant when it is ≥ 32/16. a, b, c: control, without antibiotic. a’, b’, c’:
8/4 μg/ml; a’’, b’’, c’’: 32/16 μg/ml. Controls without antibiotic (a, b, c) show the bacteria unaffected by the lysis. After 8/4, only bacteria from
the first strain, sensitive, appear lysed, showing the spread nucleoids (a’). After 32/16, first and second strains, sensitive and medium, respectively,
show to be lysed (a’’ and b’’), whereas the third strain, resistant, appears not to be lysed (c’’). Nevertheless, some isolated bacteria with
damaged cell wall are visible. When the antibiotic is effective, besides the liberation of the nucleoids, it is observed a microgranular-fibrilar
background of DNA fragments released by the bacteria.
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microgranular-fibrilar background was evident in the
cultures exposed to the antibiotics. This background
was not affected by the buffers from the enzymes (Fig-
ure 2b, c, e). Treatment with proteinase K was not effec-
tive in removing the background (Figure 2f), even when
increasing the concentration to 10 mg/ml or diluting in
water instead of the buffer, or digesting on the microgel
or in cultures fixed in methanol:acetic-acid and spread
onto slides. Nevertheless, the background disappeared
after incubation with DNase I (Figure 2d), indicating
that it corresponded to DNA fragments.
To further confirm the previous result, conventional
Fluorescence In Situ Hybridization (FISH) with a
whole genome probe specific to each bacteria, was per-
formed on cultures spread on slides. After fixation in
methanol:acetic acid (3:1), the microgranular-fibrilar
background tended to aggregate, forming clusters that
may enclose the bacteria. DAPI counterstaining pene-
trated inside the bacteria due to effects on the cell
wall, staining the nucleoids. The surrounding back-
ground also appeared stained, less intense than the
bacteria (Figure 3a). The whole genome probe labelled
the nucleoids and hybridized strongly with the aggre-
gated background (Figure 3b), confirming its bacterial
DNA nature.
In addition, when the culture of A. baumanni suscep-
tible to imipenem, was diluted 10 times and immersed
in microgel, it allowed us to visualize the background
with more detail (Figure 4). The strong staining with the
highly sensitive nucleic acid fluorochrome SYBR Gold
showed DNA fragments in different levels of spreading,
from a dot appearance to an extended fiber.
Incubation time and culture conditions
To evaluate the influence of the incubation time with
the b-lactam, three clinical strains of E. coli, one suscep-
tible (MIC: 8/4 μg/ml), one intermediate (MIC: 16/8 μg/
ml) and one resistant (MIC: > 64/32 μg/ml), were trea-
ted with amoxicillin/clavulanic acid at doses 0, 8/4 and
32/16 μg/ml for 75 min. The origin of the culture before
antibiotic treatment, either growing from 24 h in agar
dish or exponentially growing in liquid broth was also
assessed.
When coming from a culture growing 24 h in agar
plate, the susceptible strain after 20 min with the high
dose showed an initial and slight cell lysis with faint
background of extracellular DNA fragments. With the
low dose, the effect was evident after 40 min. After 60
min the effect was the maximum (like Figure 1 a’). The
intermediate strain revealed a delayed and slight effect
only after the high dose for 60 min, being more evident
after 75 min. The resistant strain never showed an
effect, although some cells appeared slightly lysed at 75
min after the high dose (like Figure 1c’’).
When the bacteria came from exponentially growing
liquid culture, the effect on the cell wall was evident
much earlier. After 10 min, the susceptible strain
Figure 2 Nature of the microgranular-fibrilar extracellular
background in an E. coli strain susceptible to ampicillin,
incubated with 32 μg/ml of the antibiotic. Control culture
without ampicillin does not show the microgranular-fibrilar
extracellular background (a), whereas it is evident in cultures treated
with ampicillin (b). Incubation of the microgels with specific buffers
for DNase I (c) or proteinase K (e) does not affect the background.
The specific proteinase K buffer lyses the bacteria. The background
disappears after incubation with DNase I (d), but not after
proteinase K treatment (f).
Figure 3 Fluorescence In Situ Hybridization (FISH) with a
specific whole genome probe on methanol:acetic acid fixed
and spread cultures from E. coli treated with ampicillin. DAPI
counterstaining (blue) evidences a faint background of aggregated
material that encloses the bacteria that appear more strongly
stained (a). The whole genome probe, revealed with Cy 3, red,
labelled the nucleoids from bacteria and strongly hybridized with
the aggregated background (b).
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showed clear effects, small at 8/4 dose but pronounced
with the 32/16 dose. After 30 min, the effect was
intense at 8/4 dose, similar to that on the culture com-
ing from agar dish after 60 min incubation. The inter-
mediate strain revealed a weak effect only after 30-40
min with the high dose, being more evident after 60
min. As in the case of cultures coming from agar
plate, the resistant strain never showed an effect,
although a few cells appeared slightly lysed after 60
min.
Dose-effect
One E. coli strain sensitive to ampicillin (MIC: 4 μg/ml)
was exposed to increasing doses of the antibiotic to
evaluate the effect on the cell wall. Qualitatively, four
categories could be easily established (Figure 5). Unaf-
fected bacteria only revealed a background effect of the
lysing solution, generally with a very restricted spreading
of some DNA fibres from the bacterial body. Affected
bacteria could show a weak effect, with a small periph-
eral halo of DNA loops emerging from the bacterial
body, or a strong effect, where the cells are lysed and
the nucleoid is completely released from the residual
bacterium. The effect may be even stronger, so the resi-
dual core from the bacterium is not recognized inside
the spread nucleoid. The measure of the halo width of
spreading of the nucleoid established 0.40 μm as the
limit of halo size between unaffected and small cell wall
damage, whereas it was 0.80 μm between low and high
cell wall damage. Furthermore, the average halo width
of spreading of the nucleoids provided a quantitative
estimation of the effect on the cell wall (Figure 6).
Figure 7 shows representative images, whereas Figure
8 reveals the proportion of the different categories of
cell wall damage with increasing doses of ampicillin. A
Figure 4 Background DNA fragments in an A. baumanii strain
susceptible to imipenem. The strain was incubated with 0.76 μg/
ml of the antibiotic. A high dilution of the culture before being
enclosed in agarose microgel allows a more detailed visualization of
the extracellular background, after SYBR Gold staining. It is
evidenced that the background corresponds to DNA fragments in
different levels of spreading, from a punctual appearance to an
extended fiber.
Figure 5 Categories of E. coli exposed to ampicillin, after
processing by the procedure to determine cell wall integrity,
determined by the spreading of the internal nucleoid. From
above to below: Unaffected, Weakly affected, Strongly affected,
Strongly affected without recognizable cell body.
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slight effect was detected in most of bacteria after 2 μg/
ml, which should not be enough to prevent viability in
most of them when incubated in medium without anti-
biotic. After the MIC dose, almost all cells showed
strong cell wall damage, with a predominance of those
where the residual cell core is not visualized within the
nucleoid after the highest doses (Figures 7, 8). In fact,
despite the similar halo width of the spread nucleoids
after 8, 12 and 16 μg/ml (Figure 6), the fraction of cells
where the core from the bacterium is not recognized
inside the nucleoid increased progressively (Figures 7,
8). The background of DNA fragments was scarce at the
MIC dose, increasing with the higher doses.
Evaluation of clinical strains
To extend the applicability of the methodology, 46 clini-
cal strains from medically relevant species, were evalu-
ated blind for susceptibility or resistance to one of four
different b-lactams. Eight gram-negative and four gram-
positive species were assayed (Table 1). Vancomycin was
also tested in gram positive enterococci and staphylo-
cocci, due to its great clinical relevance (Figure 9). The
strains were incubated with the CLSI breakpoint con-
centrations of susceptibility (low dose) and resistance
(high dose) of each antibiotic. The strain was considered
susceptible if nucleoids were released after the low dose,
intermediate if nucleoids were released only after the
high dose, and resistant if nucleoids were not released
after the high dose. The results obtained with the proce-
dure always coincided with those from the standard
techniques from the clinical laboratory. The concentra-
tion where the presence of the background of DNA
fragments was observed coincided with that where
Figure 6 Halo width of spreading of the nucleoids from the
bacterial body from E. coli after increasing doses of ampicillin.
Figure 7 Representative images of the effect of increasing doses of ampicillin in a susceptible strain of E. coli. a: control, 0 μg/ml; b: 2
μg/ml; c: MIC dose, 4 μg/ml; d: 8 μg/ml; e: 12 μg/ml.
Santiso et al. BMC Microbiology 2011, 11:191
http://www.biomedcentral.com/1471-2180/11/191
Page 6 of 14
nucleoids were released, in gram-negative strains. Never-
theless, in spite of releasing of nucleoids, the back-
ground of DNA fragments was very scarce or
undetectable in susceptible gram-positive strains at the
doses employed (Table 1 Figure 9).
Discussion
We have adapted our methodology for assessment of
susceptibility or resistance to quinolones [14-16] to
develop a simple and rapid procedure to determine sus-
ceptibility or resistance to antibiotics that act at the cell
wall. This objective may have great application since
these are by far the most frequent antibiotics employed
all over the world [1].
To assess quinolone activity, the lysing conditions of
bacteria were designed to remove the cell wall and
membranes from all the cells equally, leaving the cell
wall affected or intact [14,15]. In the case of antibiotics
that act at the cell wall, the lysis must be adapted to
only affect to those bacteria whose cell wall had been
damaged by the antibiotic. These bacteria would have a
debilitated wall, which would be much more sensitive to
the lysing conditions designed to such an effect. The
lysis affects the cells differentially, depending on the
integrity of the wall. If the bacterium is susceptible, the
weak cell wall is affected by the lysing solution so that
the nucleoid of DNA contained inside the bacterium is
released and spread. On the other hand, if the bacterium
is resistant to the antibiotic, it would be virtually unaf-
fected by the lysis solution and does not liberate the
nucleoid, remaining essentially with its usual morpholo-
gical appearance.
The present work describes a logical sequence of
experiments to achieve the objective of developing a
simple and rapid procedure to determine susceptibility
or resistance to antibiotics that act at the cell wall.
Firstly, it was necessary to demonstrate the ability of the
procedure to discriminate susceptible, intermediate and
resistant strains. This was confirmed in clinical E. coli
strains. As a consequence of the images obtained and to
provide an adequate interpretation, the nature of the
microgranular-fibrilar extracellular background observed
in the preparations was recognized. The influence of
culture conditions and incubation time on the observed
effect was explored, allowing a detailed dose-effect ana-
lysis of the b-lactam, establishing categories of cell wall
damage. Finally, the utility of the methodology was
demonstrated and extended to clinically relevant gram-
negative and gram-positive microorganisms. To our
knowledge, there are no references on our work to dis-
cuss, given the novelty of the technique.
The procedure was able to distinguish E. coli strains
that were susceptible, intermediate and resistant to
amoxicillin/clavulanic acid. Susceptible strains appeared
lysed releasing the nucleoid after the cut-off dose point
of susceptibility (8/4 μg/ml), whereas intermediate
strains only were affected by the threshold dose of resis-
tance (32/16 μg/ml). Intermediate strains were only
lysed after this latter dose. From the clinical point of
view, besides the control 0 dose, the assay with the
breakpoint dose of susceptibility could be enough to dis-
criminate susceptible from non-susceptible strains. This
may make the analysis of lots of strains very accessible
with the procedure. In fact, the important fact for the
therapeutic decision is the differentiation between sus-
ceptible or non-susceptible. Intermediate strains should
not be treated with the antibiotic, being preferable to
use an alternative one to which they are totally
susceptible.
The growing stage of the bacterial population must
influence the efficacy of the antibiotic, affecting the
kinetics of action. In fact, cells that are not growing or
in stationary phase extraordinarily decrease the suscept-
ibility to b-lactams [17]. Moreover, the effect at the cell
wall of the antibiotic is a dynamic process, concentra-
tion and time-dependent.
From the experiment of incubation time, it is deduced
that to discriminate with accuracy the susceptible strains
from the rest it is enough, in a practical clinical
approach, to assess the control 0 dose and the CLSI
cut-off dose for susceptibility, incubating with the anti-
biotic for 60 min in case of cultures growing 24 h in
agar plate, as usual in the standard clinical microbiology
laboratory. If the cultures were exponentially growing in
liquid medium, the incubation time with the antibiotic
may be decreased for 30 min. We have observed that
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Figure 8 Proportions of the different categories of cell wall
damage after increasing dose of ampicillin in susceptible E.
coli cultures.
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Table 1 Microorganisms evaluated for susceptibility-resistance to antibiotics that inhibit peptidoglycan synthesis
Gram Bacteria Antibiotics- CLSI MIC
Interpretative Standard (μg/mL)
CLSI
Category
MIC
(μg/ml)
Drug concentration at which the nucleoids were spread -
and DNA fragments were released
Gram
-
Acinetobacter
baumannii
Imipenem: ≤ 4 - 8 - ≥16 (SI, R) Susceptible 2 4-4
Gram
-
Acinetobacter
baumannii
Imipenem: ≤ 4 - 8 - ≥16 (SI, R) Intermediate 8 16-16
Gram
-
Acinetobacter
baumannii
Imipenem: ≤ 4 - 8 - ≥16 (SI, R) Resistant > 16 No nucleoids-No fragments
Gram
-
Acinetobacter
baumannii
Imipenem: ≤ 4 - 8 - ≥16 (SI, R) Resistant > 16 No nucleoids-No fragments
Gram
-
Acinetobacter
baumannii
Ceftazidime: ≤ 8 - 16 - ≥32 (S, I, R) Susceptible 4 8-8
Gram
-
Acinetobacter
baumannii
Ceftazidime: ≤ 8 - 16 - ≥32 (S, I, R) Intermediate 12 32-32
Gram
-
Acinetobacter
baumannii
Ceftazidime: ≤ 8 - 16 - ≥32 (S, I, R) Resistant > 256 No nucleoids-No fragments
Gram
-
Enterobacter
cloacae
Imipenem: ≤ 1 - 2 - ≥4 (S, I, R) Susceptible < 1 1-1
Gram
-
Enterobacter
cloacae
Imipenem: ≤ 1 - 2 - ≥4 (S, I, R) Susceptible < 1 1-1
Gram
-
Enterobacter
cloacae
Ceftazidime: ≤ 4 - 8 - ≥16 (S, I, R) Susceptible < 1 4-4
Gram
-
Enterobacter
cloacae
Ceftazidime: ≤ 4 - 8 - ≥16 (S, I, R) Susceptible < 1 4-4
Gram
-
Escherichia coli Ampicillin: ≤ 8 - 16- ≥32 (S, I, R) Susceptible 2 8-8
Gram
-
Escherichia coli Ampicillin: ≤ 8 - 16- ≥32 (S, I, R) Intermediate 12 16-16
Gram
-
Escherichia coli Ampicillin: ≤ 8 - 16- ≥32 (S, I, R) Resistant 256 No nucleoids-No fragments
Gram
-
Escherichia coli Ceftazidime: ≤ 4 -8- ≥16 (S, I, R) Susceptible 0.25 4-4
Gram
-
Escherichia coli Ceftazidime: ≤ 4 -8- ≥16 (S, I, R) Resistant 32 No nucleoids-No fragments
Gram
-
Klebsiella
oxytoca
Imipenem: ≤ 1 - 2 - ≥4 (S, I, R) Susceptible < 1 1-1
Gram
-
Klebsiella
oxytoca
Ceftazidime: ≤ 4 - 8 - ≥16 (S, I, R) Susceptible < 1 4-4
Gram
-
Klebsiella spp. Imipenem: ≤ 1 - 2 - ≥4 (S, I, R) Susceptible < 1 1-1
Gram
-
Klebsiella spp. Imipenem: ≤ 1 - 2 - ≥4 (S, I, R) Susceptible < 1 1-1
Gram
-
Klebsiella spp. Imipenem: ≤ 1 - 2 - ≥4 (S, I, R) Susceptible < 1 1-1
Gram
-
Klebsiella spp. Ceftazidime: ≤ 4 - 8 - ≥16 (S, I, R) Intermediate 8 16-16
Gram
-
Klebsiella spp. Ceftazidime: ≤ 4 - 8 - ≥16 (S, I, R) Resistant > 16 No nucleoids-No fragments
Gram
-
Klebsiella spp. Ceftazidime: ≤ 4 - 8 - ≥16 (S, I, R) Resistant > 16 No nucleoids-No fragments
Gram
-
Morganella
morganii
Imipenem: ≤ 1 - 2 -≥4 (S, I, R) Intermediate 2 4-4
Gram
-
Morganella
morganii
Ceftazidime: ≤ 4 - 8 -≥16 (S, I, R) Susceptible < 1 4-4
Gram
-
Proteus
mirabilis
Imipenem: ≤ 1 - 2 - ≥4 (S, I, R) Intermediate 2 4-4
Santiso et al. BMC Microbiology 2011, 11:191
http://www.biomedcentral.com/1471-2180/11/191
Page 8 of 14
the greater the ageing of the culture in agar plate, or
when the culture is achieving the stationary phase of
growth, the longer the incubation time necessary to
observe the effect of the antibiotic, even several hours.
To evaluate clinical strains using the technique to assess
the integrity of the cell wall, it is mandatory to simulta-
neously process a sensitive, an intermediate and a resis-
tant strain as controls of the activity of the antibiotic
and the efficacy of the technique.
Sensitive strains from gram-negative bacteria assayed
showed a background of extracellular microgranular-
fibrilar material, its concentration being dose and time
dependent. This material corresponded to DNA frag-
ments released by the bacteria, since it was digested by
DNase I and hybridized with a specific whole genome
probe, being clearly visualized with high sensitive DNA
dyes, i.e. SYBR Gold. It is interesting to note that this
background of DNA fragments was practically undetect-
able in gram-positive strains, despite being susceptible
to b-lactams or vancomycin. Moreover, it was also
undetected in the same bacteria after quinolone treat-
ment in susceptible strains, as evidenced in our previous
works with the procedure [15,16]. This fact suggests
that the release of DNA fragments could be specific to
cell wall directed antibiotics or b-lactams at least.
This interesting phenomenon requires a deeper study
in future works, to address the mechanisms and kinetics
of production. DNA fragmentation must be a secondary
effect, after cell wall damage. It could be a passive result
of attack by DNases or reactive species of oxygen (ROS)
Table 1 Microorganisms evaluated for susceptibility-resistance to antibiotics that inhibit peptidoglycan synthesis
(Continued)
Gram
-
Proteus
mirabilis
Ceftazidime: ≤ 4 - 8 - ≥16 (S, I, R) Susceptible < 1 4-4
Gram
-
Salmonella spp Imipenem: ≤ 1 - 2 - ≥4 (S, I, R) Susceptible < 1 1-1
Gram
-
Salmonella spp Ceftazidime: ≤ 4 - 8 - ≥16 (S, I, R) Susceptible < 1 4-4
Gram
+
Enterococcus
faecalis
Ampicillin: ≤ 8 - ≥16 (S, R) Susceptible 4 8-No fragments
Gram
+
Enterococcus
faecalis
Penicillin: ≤ 8 - ≥16 (S, R) Susceptible 2 8-No fragments
Gram
+
Enterococcus
faecalis
Vancomycin: ≤ 4 -8/16- ≥32 (S, I, R) Resistant > 32 No nucleoids-No fragments
Gram
+
Enterococcus
faecium
Ampicillin: ≤ 8 - ≥16 (S, R) Resistant > 32 No nucleoids-No fragments
Gram
+
Enterococcus
faecium
Penicillin: ≤ 8 - ≥16 (S, R) Resistant > 32 No nucleoids-No fragments
Gram
+
Enterococcus
faecium
Vancomycin: ≤ 4 -8/16- ≥32 (S, I, R) Susceptible < 1 4-No fragments
Gram
+
Enterococcus
spp.
Ampicillin: ≤ 8 - ≥16 (S, R) Susceptible < 1 8-No fragments
Gram
+
Enterococcus
spp.
Ampicillin: ≤ 8 - ≥16 (S, R) Intermediate 12 16-No fragments
Gram
+
Enterococcus
spp.
Ampicillin: ≤ 8 - ≥16 (S, R) Resistant > 16 No nucleoids-No fragments
Gram
+
Enterococcus
spp.
Penicillin: ≤ 8 - ≥16 (S, R) Susceptible 2 8-No fragments
Gram
+
Enterococcus
spp.
Penicillin: ≤ 8 - ≥16 (S, R) Resistant > 16 No nucleoids-No fragments
Gram
+
Enterococcus
spp.
Vancomycin: ≤ 4 -8/16- ≥32 (S, I, R) Susceptible 2 4-No fragments
Gram
+
Enterococcus
spp.
Vancomycin: ≤ 4 -8/16- ≥32 (S, I, R) Resistant > 32 No nucleoids-No fragments
Gram
+
Enterococcus
spp.
Vancomycin: ≤ 4 -8/16- ≥32 (S, I, R) Resistant > 32 No nucleoids-No fragments
Gram
+
Staphylococcus
aureus
Vancomycin: ≤2 - 4-8 - ≥16 (S, I, R) Susceptible < 1 2-No fragments
Gram
+
Staphylococcus
aureus
Vancomycin: ≤2 - 4-8 - ≥16 (S, I, R) Susceptible < 1 2-No fragments
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liberated in the affected bacteria, or it could be active, a
consequence of an apoptotic-like process triggered after
cell wall damage. Considering to the first possibility, it
has been recently reported that, unlike bacteriostatic
antibiotics, b-lactams induce the formation of ROS in
gram-negative and gram-positive microorganisms [18].
Hydroxyl radicals should attack proteins and DNA, pos-
sibly inducing DNA breakages, resulting in death of the
bacteria. This response was also found with other bac-
tericidal antibiotics, like fluoroquinolones. Possibly, the
increased permeability of the cell wall that would result
after impairment of peptidoglycan biosynthesis by the b-
lactams, would allow the release of DNA fragments to
the medium. Nevertheless, the DNA fragments that
result by the particular effect of quinolones through
trapping of DNA gyrase and topoisomerase IV on chro-
mosomal DNA and/or by possible ROS attack [18,19],
could not be released out of the bacterium since the cell
wall would be intact initially, at least. In the case of
gram-positive bacteria, it should be analyzed more con-
fidently if DNA fragmentation is produced after b-lac-
tam treatment, although more delayed than in gram-
negative. If this is the case, despite of the effect, the
thicker cell wall of gram-positive bacteria would also
prevent the release of DNA fragments.
From the practical point of view, the background of
DNA fragments was visualized without the necessity of
incubation in lysing solution or any manipulation, so it
could be used for a rapid determination of sensitivity or
resistance, in liquid cultures. Nevertheless, the presence
of the background could be indicative of susceptibility
only in gram-negative bacteria, in those here assayed at
least. Furthermore, the dilution of the culture modifies
the density of the background, and different bacteria
and different strains may show important differences in
the amount of extracellular DNA fragments. A more
confident discrimination between sensitive and resistant
strains is achieved when also evaluating the cell wall
response to the specific lysing solution.
The dose-response study shows that the b-lactam
induces a progressive effect with increasing dose on the
cell wall. This effect is evident even before the MIC
dose, although it is very weak and seems not prevent
growth of most of bacteria after removing the antibiotic.
The cell wall damage is not homogeneous among cells,
although a predominant level is observed for each dose.
This level is more intense as dose increases. The hetero-
geneity in the effect on the cell wall is not mainly
dependent on the growing stage since the cultures were
exponentially growing when exposed to ampicillin. The
background of DNA fragments appears to be observed
at the MIC dose, and increases as dose increases, within
the range of doses assayed.
The methodology has been confirmed as a rapid and
simple procedure to distinguish susceptible and resistant
strains of eight gram-negative and four gram-positive
Figure 9 Two strains of Enterococcus spp., one resistant (above: a, b, c) and one susceptible (below: d, e, f), exposed to vancomycin, 0
μg/ml (left: a, d), 4 μg/ml (medium: b, e) and 32 μg/ml (right: c, f) and processed by the procedure to assess cell wall integrity.
Whereas the resistant strain does not show lysis after vancomycin doses, the sensitive strain is clearly affected. There is no evidence of
background of extracellular DNA fragments.
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species, assaying four different b-lactams and vancomy-
cin. The results were reproducible and accurate, in the
46 clinical strains. Although preliminary, the results are
encouraging. Expanded work analysing many more
strains is in progress. For example, links have been
established between glycopeptide resistance and cell wall
thickening in vancomycin-intermediate Staphylococcus
aureus (VISA), as well as between macrolides and thick-
ened cell walls in S. aureus [20,21]. These are interesting
strains to be tested. Furthermore, the examination of the
slides is going to be automated using a microscopy plat-
form coupled with image capture and digital image ana-
lysis. This will allow a high-throughput examination of
large numbers of microorganisms, for a rapid identifica-
tion of resistant and susceptible strains to antibiotics
that interfere with peptidoglycan biosynthesis.
Conclusion
The technique to assess cell wall integrity may be a
rapid and simple procedure to discriminate resistant and
susceptible strains to antibiotics that interfere with pep-
tidoglycan biosynthesis. The methodology may be useful
not only at the clinical level but also to perform basic
studies about the mechanisms of action of antibiotics
that act at the cell wall.
Methods
Cultures, bacterial strains and experiments
In an initial approach to evaluate the procedure to
determine cell wall integrity, ten clinical strains from
Escherichia coli, isolated from urine samples in the
microbiology service, were tested blind for susceptibility
or resistance to amoxicillin/clavulanic acid. According
to the Clinical and Laboratory Standards Institute
(CLSI) criteria (susceptible: minimum inhibitory concen-
tration - MIC ≤ 8/4; 8 μg/ml amoxicillin/4 μg/ml clavu-
lanic acid; resistant: MIC ≥ 32/16; 32 μg/ml amoxicillin/
16 μg/ml clavulanic acid), two strains were categorized
as susceptible, five intermediate and three resistant. In
this experiment, bacteria were growing in Mueller-Hin-
ton agar at 37°C for 24 h. Then, they were diluted to an
OD600 of 0.1 in Mueller-Hinton broth with 0, 8/4 and
32/16 μg/ml amoxicillin/clavulanic acid, incubated at
37°C for 60 min, and processed to determine cell wall
integrity.
In a second experiment, the effect of the incubation
time with the antibiotic was analyzed, after treatment
with 8/4 and 32/16 μg/ml amoxicillin/clavulanic acid, in
three clinical strains of E. coli isolated from urine sam-
ples, one susceptible (MIC: 8/4 μg/ml), one intermediate
(MIC: 16/8 μg/ml) and one resistant (MIC: > 64/32 μg/
ml). Moreover, it was tested both in cultures exponen-
tially growing in Mueller-Hinton broth at 37°C, with
aeration and shaking, and in cells cultured for 24 h in
Mueller-Hinton agar dishes, as usual in the standard
clinical microbiology laboratories. Cells were diluted to
an OD600 of 0.1 in Mueller-Hinton broth, and incu-
bated with the two doses of the antibiotic for 5, 10, 20,
30, 40, 60 and 75 min.
Thirdly, a dose-response experiment at the cell wall
level of one E. coli strain isolated from an urine sample,
susceptible to ampicillin (MIC: 4 μg/ml), was performed.
Bacteria exponentially growing in Mueller-Hinton broth
were diluted to an OD600 of 0.1 in Mueller-Hinton
broth and then incubated for 60 min with 0, 1, 2, 4, 8,
12, 16 μg/ml ampicillin. Afterwards, the cultures were
processed to determine viability and cell wall integrity.
The halo size of the nucleoid was measured in 250-400
bacteria per dose after image capture and digital image
analysis, and included in one of four qualitative cate-
gories: undamaged, with low cell wall damage, with high
cell wall damage where the residual body of the bacter-
ium was retained, and with high cell wall damage where
the residual core from the bacterium was not
recognized.
In a fourth approach, a total of 46 different clinical
strains from eight different gram-negative and four
gram-positive clinically relevant microorganisms, ran-
domly selected in the clinical microbiology laboratory,
were tested blind for susceptibility or resistance to one
of four different b-lactams, either two penicillins (peni-
cillin, ampicillin), or a third-generation cephalosporin
(ceftazidime), or a carbapenem (imipenem), or vancomy-
cin. Between 2009-2010 a total of 46 clinical isolates:
Enterobacteriaceae (Escherichia coli, Enterobacter cloa-
cae, Klebsiella spp.; including 2 K. oxytoca, Morganella
morganii, Proteus mirabilis, Salmonella spp.), Acineto-
bacter baumannii, Enterococcus spp. (E. faecalis and E.
faecium), and Staphylococcus aureus were collected
from the A Coruña Hospital, NW Spain, and were
included in the study (Table 1). Isolates were identified
by API 20NE, API 20E, API 20STREP, and API STAPH
(bioMérieux, Marcy l’Etoile, France) when appropriated.
With A. baumannii, the identification was confirmed by
molecular methods. Only one strain per patient was
selected and in all cases bacterial isolates were asso-
ciated with infection. All strains were isolated from
urine samples (urinary tract infection), except those 7
from A. baumannii, 3 isolated from blood, 3 from
respiratory samples, and 1 from wound infection. The
microorganisms assayed, antibiotics employed and the
CLSI breakpoint concentrations of susceptibility-resis-
tance are presented in Table 1. Bacteria were grown for
24 h in Mueller-Hinton agar dishes. After dilution to an
OD600 of 0.1, the bacteria were incubated with the
CLSI breakpoint doses of susceptibility and resistance in
Mueller-Hinton broth at 37°C, for 60 min and processed
to determine cell wall integrity.
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Cell growth in Mueller-Hinton broth was evaluated by
monitoring turbidity at OD600 using a spectrophot-
ometer (Unicam 8625, Cambridge, UK). The MIC was
determined by automated microdilution (MicroScan
Walkaway, Dade) or using the E-test (AB Biodisk, Solna,
Sweden) according to manufacturer’s instructions. Viabi-
lity was determined by colony counting after sequential
dilutions and plating.
Determination of cell wall integrity
The Micromax® kit (Halotech DNA SL, Madrid, Spain)
had been designed to evaluate the integrity of the
nucleoid from bacteria. Two new variants of the Micro-
max® kit were used, one developed to assess the cell
wall from gram-negative bacteria (Micromax® WG-)
and another one for gram-positive bacteria (Micromax®
WG+). An aliquot of each sample was diluted to a con-
centration of 5-10 million microorganisms/ml in Muel-
ler-Hinton broth. The kit includes 0.5 ml snap cap
microfuge tubes containing gelled aliquots of low-melt-
ing point agarose. The tube was placed in a water bath
at 90-100°C for about 5 min to melt the agarose com-
pletely and then placed in a water bath at 37°C. Twenty-
five microlitres of the diluted sample were added to the
tube and mixed with the melted agarose. A 20 μl aliquot
of the sample-agarose mixture was pipetted onto a pre-
coated slide, and the sample was covered with a 22 × 22
mm coverslip. The slide was placed on a cold plate in
the refrigerator (4°C) for 5 min to allow the agarose to
produce a microgel with the trapped intact cells inside.
The coverslip was removed gently, and the slide was
immediately immersed horizontally in 10 ml of the lys-
ing solution for 5 min at 37°C for gram-positive bacteria
or at room temperature (22°C) in case of gram-negative
bacteria. The slide was washed horizontally in a tray
with abundant distilled water for 3 min, dehydrated by
incubating horizontally in cold (-20°C) ethanol of
increasing concentration (70%, 90%, and 100%) for 3
min each, and air-dried in an oven.
The dried slide was incubated in a microwave oven at
750 W for 4 min, and the DNA was stained with 25 μl
of the fluorochrome SYBR Gold (Molecular Probes,
Eugene, OR, USA) diluted 1:400 in TBE buffer (0.09 M
Tris-borate, 0.002 M EDTA, pH 7.5) for 2 min in the
dark, with a glass coverslip. After a brief wash in phos-
phate buffer pH 6.88 (Merck, Darmstadt, Germany), a
24 × 60 mm coverlisp was added and the slides visua-
lized under fluorescence microscopy.
In situ digestion with proteinase K and with DNase I
Many cultures sensitive to beta-lactams showed a diffuse
microgranular-fibrilar background. To investigate the
nature of this background, in situ digestion with
enzymes and Fluorescence In Situ Hybridization (FISH)
with a whole genome probe were performed.
One strain of E. coli susceptible to ampicillin, isolated
from an urine sample, was incubated with this antibiotic
(32 μg/ml) and another strain of A. baumannii, isolated
from a respiratory sample, was incubated with imipenem
(0.76 μg/ml), in Mueller-Hinton broth at 37°C for 60
min, with aeration and shaking. Afterwards, three
microgels (18 × 18 mm) on each slide were prepared for
each microorganism, as described before, but without
the lysis step. One microgel corresponded to the control
culture without antibiotic, and the other two, to the cul-
ture incubated with the antibiotic. Some slides were
washed by immersion in proteinase K buffer (SDS 1%,
EDTA 2 mM, pH 7.5) and some slides were washed in
DNase I buffer (Tris-HCl 20 mM, MgCl2 2 mM, pH
8.3), three times, 5 min each. In the first case, whereas
one of the microgels from the culture treated with the
antibiotic was only incubated with the proteinase K buf-
fer, the other microgel was incubated with proteinase K
in buffer (2 mg/ml). In the case of the slides washed
with the DNase I buffer, one of the microgels from the
culture treated with the antibiotic was only incubated
with the DNase I buffer and the other microgel was
incubated with 2.5 U DNase I in buffer. Incubations
were performed after covering with a glass coverslip, at
37°C, 30 min, in a humid chamber. Finally, the slides
were washed in distilled water, dehydrated in increasing
ethanol baths (70%-90%-100%) 5 min each, air dried
and stained with SYBR Gold (1:400).
Fluorescence In Situ Hybridization (FISH)
Fifty μl of each liquid culture of susceptible E. coli and
A. baumannii, incubated with ampicillin and imipenem
respectively as described previously, were mixed with
950 μl of methanol:acetic-acid (3:1), one drop being
spread onto glass slides and air-dried. The slides were
immersed in methanol:acetic-acid (3:1) 5 min and air-
dried again. Then, they were incubated with increasing
ethanol baths (70-90-100%), -20°C, 5 min each, and air-
dried. DNA was denatured by immersion in 75% forma-
mide/2 × SSC, pH7, 67°C, 90 sec and then the slides
were immersed in increasing ethanol baths (70-90-
100%), -20°C, 5 min each, and air-dried.
Whole genome DNA probes to label the total DNA
from E. coli and from A. baumannii were prepared.
DNA from each microorganism was isolated using stan-
dard procedures, and was labelled with biotin-16-dUTP,
using a nick translation kit, according to the manufac-
turer’s instructions (Roche Applied Science, San Cugat
del Vallés, Spain). The DNA probes were mixed at 4.3
ng/μl in the hybridization buffer (50% formamide/2 ×
SSC, 10% dextran sulfate, 100 mM calcium phosphate,
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pH 7.0) (1 × SSC is 0.015 M NaCitrate, 0.15 M NaCl,
pH 7.0). The probes in hybridization buffer were dena-
tured by incubation at 80°C for 8 min and were then
incubated on ice.
The DNA probe solutions (15 μl) were pipetted onto
the denatured and dried slides, covered with a glass cov-
erslip (22 × 22 mm) and incubated overnight at 37°C, in
the dark, in a humid chamber. The coverslip was
removed, and the slides were washed twice in 50% for-
mamide/2 × SSC, pH 7.0, for 5 min, and twice in 2 ×
SSC pH 7.0, for 3 min, at 37°C. The slides were incu-
bated with blocking solution (4 × SSC, 0.1% Triton X-
100, 5%BSA) for 5 min, covered with a plastic coverslip,
in a humid chamber, at 37°C. This solution was dec-
anted, and the bound probe was detected by incubation
with streptavidin-Cy3 (Sigma Chem, St Louis, MN,
USA) in 4 × SSC, 0.1% Triton X-100, 1%BSA (1:200),
covered with a plastic coverslip, in a humid chamber at
37°C. After washing in 4 × SSC, 0.1% Triton X-100,
three times, 2 min each, slides were counterstained with
DAPI (1 μg/ml) in Vectashield (Vector, Burlingame,
CA).
Fluorescence Microscopy and Digital Image Analysis
Images were viewed with an epifluorescence microscope
(Nikon E800), with a 100× objective and appropriate
fluorescence filters for FITC-SYBR Gold (excitation 465-
495 nm, emission 515-555 nm), PI-Cy3 (excitation 540/
25 nm, emission 605/55 nm) and DAPI (excitation 340-
380 nm, emission 435-485 nm). In the experiment of
dose-response to ampicillin, images were captured with
a high-sensitivity CCD camera (KX32ME, Apogee
Instruments, Roseville, CA). Groups of 16 bit digital
images were obtained and stored as .tiff files. Image ana-
lysis used a macro in Visilog 5.1 software (Noesis, Gif
sur Yvette, France). This allowed for thresholding, back-
ground subtraction, and measurement of the average
halo width size of the nucleoids in μm, delimitated
between the peripheral edge of the nucleoid and the
external limit of the cell body. In the case of unrecog-
nized cell body, the centroid of the nucleoid was consid-
ered as the internal reference point to measure the halo
width of the spread nucleoid.
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